Campaigners are urging lawmakers to consider the challenges facing people who rely on access for medical purposes.
The first academic research on Switzerland’s landmark adult-use pilot, has reported a decline in problematic consumption, particularly among those who used other drugs in addition to...
The concept of the medical cannabis card originated out of the US in some jurisdictions where patients are issued an annual card from their doctor which...
The preliminary findings from Switzerland’s seven active pilot trials, involving around three per cent of the country’s active cannabis consumers, have been published by a local university....
Switzerland has approved a draft proposal to establish a fully commercial adult-use cannabis market.
The first data collected from the Grashaus Project in the canton of Basel-Landschaft has been published.
The pilot in canton Zurich will include up to 7,500 participants and is the first to include a randomised control trial as part of the research.
A sixth pilot for the sale of adult-use cannabis has been approved in Basel-Landschaft.
Your weekly debrief of the latest cannabis news.
Swiss company Cannavigia is supporting the pilot with its track and trace software.
